Page 6 - Mark Lampert News Today

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...

Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually dont make them change their opinion towards a...

In this article, we examined Mark Lampert’s investment philosophy and decades of experience in the biotechnology space.

Below is the list of 5 pharma stocks to buy according to Mark Lampert’s Biotechnology Value Fund.

While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious...

Were Hedge Funds Right About ContraFect Corp (CFRX)? In this article we will analyze whether ContraFect Corp (NASDAQ:CFRX) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There’s no better way to get these firms’ immense resources and analytical capabilities working for us than to follow their lead into their best ideas. While not all of these picks will be winners, our research shows that these picks historically...

Were Hedge Funds Right About Repare Therapeutics Inc. (RPTX)? The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F filings disclosed the funds’ positions on March 31st. We at Insider Monkey have made an extensive da...